ArticleClinical and experimental medicine2015

The metalloproteinase ADAM17 and the epidermal growth factor receptor (EGFR) signaling drive the inflammatory epithelial response in Sjögren's syndrome.

Margherita Sisto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.